Literature DB >> 11600301

The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stability-indicating assay.

M Bakshi1, B Singh, A Singh, S Singh.   

Abstract

The present study describes degradation of ornidazole under different ICH prescribed stress conditions (hydrolysis, oxidation and photolysis), and establishment of a stability-indicating reversed-phase HPLC assay. Degradation was found to occur in alkaline medium, under high acidic conditions, under oxidative stress, and also in the presence of light in acid conditions. Previously the drug is only known to decompose under alkaline conditions. Separation of drug and the degradation products under various conditions was successfully achieved on a C-18 column utilising water-acetonitrile in the ratio of 86:14. The detection wavelength was 310 nm. The method was validated with respect to linearity, precision, accuracy, selectivity, specificity and ruggedness. The response was linear in the drug concentration range of 5-500 microg ml(-1). The mean values (+/-RSD) of slope, intercept and correlation coefficient were 45251 (+/-1.59), 104418 (+/-2.49) and 0.9996 (+/-0.03), respectively. The RSD values for intra- and inter-day precision studies were <1 and <2.6%, respectively. The recovery of the drug ranged between 100-103% from a mixture of degradation products. The method was specific to drug and also selective to degradation products.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600301     DOI: 10.1016/s0731-7085(01)00475-7

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation.

Authors:  Vijay Ram; Govind Kher; Kapil Dubal; Bhavesh Dodiya; Hitendra Joshi
Journal:  Saudi Pharm J       Date:  2011-03-21       Impact factor: 4.330

2.  Simultaneous Determination of Ofloxacin and Ornidazole in Solid Dosage Form by RP-HPLC and HPTLC Techniques.

Authors:  Manisha Puranik; D V Bhawsar; Prachi Rathi; P G Yeole
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

3.  Development and validation of a specific stability indicating high performance liquid chromatographic method for valsartan.

Authors:  Ks Rao; N Jena; Meb Rao
Journal:  J Young Pharm       Date:  2010-04

4.  Evaluation of degradation kinetics and physicochemical stability of tenofovir.

Authors:  Vivek Agrahari; Sandeep Putty; Christiane Mathes; James B Murowchick; Bi-Botti C Youan
Journal:  Drug Test Anal       Date:  2014-05-12       Impact factor: 3.345

5.  Degradation of the antibiotic ornidazole in aqueous solution by using nanoscale zero-valent iron particles: kinetics, mechanism, and degradation pathway.

Authors:  Yanchang Zhang; Lin Zhao; Yongkui Yang; Peizhe Sun
Journal:  RSC Adv       Date:  2018-10-12       Impact factor: 3.361

6.  Simultaneous voltammetric determination of nitazoxanide and ofloxacin in pharmaceutical formulation.

Authors:  Shital Gandhi; V Mehta; Sadhana Rajput
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

7.  Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH101; a New Synthesized COX2 Inhibitor after I.V. and Oral Administration in Male and Female Rats.

Authors:  Hoda Bahmanof; Simin Dadashzadeh; Afshin Zarghi; Alireza Shafaati; Seyed Mohsen Foroutan
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

8.  Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH102, a New Synthesized COX2 Inhibitors after I.V. and Oral Administration in Male and Female Rats.

Authors:  Hoda Bahmanof; Simin Dadashzadeh; Afshin Zarghi; Alireza Shafaati; Seyed Mohsen Foroutan
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.